Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Parent-FORT: Fear of Cancer Recurrence therapy for parents of childhood cancer survivors

Official title: Addressing Fear of Cancer Recurrence in Parents of Pediatric Cancer Survivors: Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

Run by University of Ottawa · NCT06872840 · Data updated 2026-11-12

This pilot tests a virtual group therapy called Parent-FORT to see if it reduces fear of cancer recurrence and improves quality of life for parents of childhood cancer survivors.

More Breast Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment36 (estimated)
SponsorUniversity of Ottawa
Academic / other
Locations1 site (Ottawa, Ontario)
StatusRecruiting
StartedAugust 26, 2025
Main results expectedAugust 26, 2026
Study endsMay 26, 2027
Registry record updatedSeptember 22, 2025
Trial IDNCT06872840 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking parents or primary caregivers living in Canada of a child under 18 who completed cancer treatment at least one month ago, who have clinical FCR (FCRI-SF-P ≥13) and internet access.

Probably not a fit

Parents who are non-English speakers, whose child is now an adult (≥18), whose child has active unstable graft-versus-host disease after transplant, who have unmanaged serious mental health conditions, or who are already in a therapist-led psychosocial group are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot will recruit 36 parents in Canada to participate in four videoconference groups (two intervention groups and two waitlist-control groups) led by three experienced therapists. Eligible parents must score ≥13 on the FCRI-SF-P, have internet access, and be at least one month post their child's completion of active treatment. The study will measure feasibility and acceptability (recruitment, attendance, participation, and parent satisfaction) and collect preliminary clinical outcomes on fear of recurrence and quality of life. Predefined recruitment thresholds over a 15-month period will guide decisions about feasibility for a larger multicenter randomized trial.

Why it matters

Potential benefit: If successful, Parent-FORT could reduce parents' fear of cancer recurrence and improve their quality of life using a brief virtual group format.

How similar studies have gone: Similar brief FCR interventions and group therapies have shown benefit for adult cancer survivors, but Parent-FORT is novel because these approaches have not been tested specifically with parents of childhood cancer survivors.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parent (or primary caregiver) caring for a childhood cancer survivor (\<18 years of age) of any type of cancer type, who is at least 1 months from the completion of active treatment and has not had a recurrence of their cancer
* A score of 13 or greater on the Fear of Cancer Recurrence Inventory-Short Form-Parent version (FCRI-SF-P; range 0-36), suggesting clinical levels of FCR
* Access to a computer and internet connection
* Living in Canada

Exclusion Criteria:

* Being the parent of a pediatric cancer survivor who is now 18 years of age or older
* Being the parent of a pediatric cancer survivor who has undergone hematopoietic cell transplantation and has active chronic or acute graft-versus-host disease which has not stabilized for at least 3 months
* Non-English speakers
* Currently participating in another therapist-led psychosocial therapy group
* Parent with unmanaged/undermanaged mental health disorder judged to be clinically contraindicated and/or likely to affect the group work
* To avoid violating the assumption of nonindependence of the data, only one parent/caregiver per child can participate in the study.

Where it's running

  • University of Ottawa
    Ottawa, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Sophie Lebel, PhD — University of Ottawa
  • Study coordinator: Celeste Holy, B.A
  • Email: choly@uottawa.ca
  • Phone: 6135625800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.